tiprankstipranks
Shield Therapeutics PLC (GB:STX)
LSE:STX
STX
Shield Therapeutics
RESEARCH TOOLSreports
Want to see GB:STX full AI Analyst Report?

Shield Therapeutics (STX) Revenue

42 Followers
StatisticsMarket CapRevenue

Shield Therapeutics Revenue

Shield Therapeutics had a revenue of 28.39M in the quarter ending Dec 31, 2025, with 71.64%. This bring the company's revenue in the last twelve months to 44.93M, Decreased 40.09%. In the fiscal year ending Dec 31, 2025, Shield Therapeutics had annual revenue of 50.74M with 101.49% growth.
Revenue (ttm)
44.93M
Revenue Growth
49.81%
P/S Ratio
1.86
Revenue/Employee
£805,456
Employees
63
Market Cap
£94.56M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
50.74M25.56M+101.49%
Dec 31, 2024
25.18M12.10M+92.46%
Dec 31, 2023
13.09M7.59M+137.95%
Dec 31, 2022
5.50M3.98M+262.01%
Jun 30, 2022
1.52M-8.87M-85.38%
Dec 31, 2020
10.39M9.67M+1,344.65%
Dec 31, 2019
719.00K-11.16M-93.95%
Dec 31, 2018
11.88M11.24M+1,765.15%
Dec 31, 2017
637.00K――